Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 1, 2011, Pages

  Cairns, K Lisa ^a   Perry, Robert T ^a   Ryman, Tove K ^a   Nandy, Robin K ^b   Grais, Rebecca F ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNICEF   (United States)

^c EPICENTRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ARTICLE; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; INCIDENCE; INCOME; INFECTION CONTROL; LOWEST INCOME GROUP; MASS IMMUNIZATION; MEASLES; MEASLES VACCINATION; MEDICAL RECORD REVIEW; MIDDLE INCOME COUNTRY; MORBIDITY; MORTALITY; OUTBREAK RESPONSE IMMUNIZATION; PRIORITY JOURNAL; SOCIAL STATUS; SYSTEMATIC REVIEW; ADOLESCENT; AFRICA; ASIA; CHILD; DEVELOPING COUNTRY; ECONOMICS; EUROPE; HEALTH; IMMUNIZATION; INFANT; MIDDLE EAST; PRESCHOOL CHILD; REVIEW; WESTERN HEMISPHERE;

ADOLESCENT; AFRICA; AMERICAS; ASIA; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DISEASE OUTBREAKS; EUROPE; HUMANS; IMMUNIZATION; INFANT; MEASLES; MEASLES VACCINE; MIDDLE EAST; WORLD HEALTH;

EID: 79960880816     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir072     Document Type: Article

References (58)

1. CDC. Global Measles Mortality, 2000-2008. MMWR Morb Mortal Wkly Rep 2009; 58:1321-6.
2. World Health Organization. The immunological basis for immunization series. Module 7: Measles Update. Geneva, Switzerland: WHO Press, World Health Organization, 2009.
3. Gay N. The theory of measles elimination: implications for the design of elimination strategies. J Infect Dis 2004; 187(Suppl 1):S27-35.
4. Strebel PM, Papania MJ, Dayan G, Halsey NA. Measles vaccine. In Plotkin SA, Orenstein WA, Offitt P eds: Vaccines, 5th ed. Philadelphia: Saunders, 2008; pp. 354.
5. Toole MJ, Steketee RW, Waldman RJ, Neiburg P. Measles prevention and control in emergency settings. Bull World Health Organ 1989; 67:381-8.
6. Strebel PM, Papania MJ, Dayan G, Halsey NA. Measles vaccine. In Plotkin SA, Orenstein WA, Offitt P eds: Vaccines, 5th ed. Philadelphia: Saunders, 2008; pp. 364.
7. Berkovich S, Starr S. Use of live-measles-virus vaccine to abort an expected outbreak of measles within a closed population. N Engl J Med 1963; 269:75-7.
8. Fulginiti VA, Kempe CH. Measles exposure among vaccine recipients: responses to measles exposure and antibody persistence among recipients of measles vaccines. Am J Dis Child 1963; 106:450-61.
9. Fulginiti V. Simultaneous measles exposure and immunization. Arch Gesamte Virusforsch 1965; 16:300-4.
10. Ruuskanen O, Salmi TT, Halonen P. Measles vaccination after exposure to natural measles. J Pediatr 1978; 93:43-6.
11. Medecins sans Frontieres. Refugee health. An approach to emergency situations. London, Basingstoke: MacMillan Education Ltd, 1997; pp. 175.
12. WHO/UNICEF. Joint Statement on reducing measles mortality in emergencies. http://whqlibdoc.who.int/hq/2004/WHO-V&B-04.03.pdf.
13. Grais RF, De Radigues X, Dubray C, Fermon F, Guerin PJ. Exploring the time to intervene with a reactive mass vaccination campaign in measles epidemics. Epidemiol Infect 2006; 134:845-9.
14. Aylward RB, Clements J, Olive JM. The impact of immunization control activities on measles outbreaks in middle and low income countries. Int J Epidemiol 1997; 26:662-9.
15. World Health Organization. Guidelines for epidemic preparedness and response to measles outbreaks. WHO/CDS/CSR/ISR/99.1. Geneva, Switzerland: WHO Press, World Health Organization, 1999.
16. Response to measles outbreaks in measles mortality reduction settings. Geneva: World Health Organization, 2009. WHO/IVB/09.03. http://www.who.int/ immunization/documents/WHO-IVB-09.03/en/index. html).
17. CDC. Absence of transmission of d9 measles virus - Region of the Americas, Nov 2002-March 2003. MMWR Morb Mortal Wkly Rep 2003; 52:228.
18. Katz SL, Hinman AR. Summary and Conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis 2004; 189(Suppl 1):S43-47.
19. World Health Organization. Measles vaccines: WHO position paper. Wkly Epidemiol Rec 2009; 35:349-60.
20. CDC. Progress in measles control-Nepal, 2000-2006. MMWR Morb Mortal Wkly Rep 2007; 56:1028-31.
21. CDC. Progress in measles control-Kenya 2002-2007. MMWR Morb Mortal Wkly Rep 2007; 56:969-72.
22. http://go.worldbank.org/K2CKM78CC0. Accessed 31 March 2010.
23. Mgone JM, Mgone CS, Duke T, Frank D, Yeka W. Control measures and the outcome of the measles epidemic of 1999 in the Eastern Highlands Province. P N G Med J 2000; 43:91-7.
24. Benjamin AL, Dramoi V. Outbreak of measles in the national capital District, Papua New Guinea in 2001. P N G Med J 2002; 45:174-84.
25. Guris D, Auerbach SB, Vitek C, et al. Measles outbreaks in Micronesia, 1991-1994. Pediatr Infect Dis J 1998; 17:33-9.
26. CDC. Measles outbreak-Guam, 1994. MMWR Morb Mortal Wkly Rep 1995; 44:657-60.
27. Hyde TB, Nandy R, Hickman CJ, et al. Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003. Bull World Health Organ 2009; 87:93-8.
28. Hyde TB, Dayan GH, Langidrik JR, et al. Measles outbreak in the Republic of the Marshall islands, 2003. Int J Epidemiol 2006; 35:299-306.
29. CDC. Public health dispatch: measles epidemic-Majuro atoll, Republic of the Marshall islands, July 13-September 13, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:888-9.
30. Marin M, Nguyen HQ, Langidrik JR, et al. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. Clin Infect Dis 2006; 42:315-9.
31. Rafai E. An outbreak of measles, Koro island, 1997. Pac Public Health 2006; 13:2.
32. CDC. Measles outbreak and response-Fiji, February-May 2006. MMWR Morb Moral Wkly Rep 2006; 55:963-6.
33. Al Wahaibi S, El-Bushra HE, Al-Sulaiman MA. Measles outbreak in Riyadh city, 1997. Saudi Epidemiol Bull 1997; 4:4-5.
34. CDC. Emergency measles control activities-Darfur, Sudan, 2004. MMWR Morb Mortal Wkly Rep 2004; 52:897-9.
35. Santos JI, Nakamura MA, Godoy MV, et al. Measles in Mexico, 1941-2001: Interruption of endemic transmission and lessons learned. J Infect Dis 2004; 189(Suppl 1):S243-50.
36. CDC. Progress toward measles elimination-region of the Americas, 2002-2003. MMWR Morb Mortal Wkly Rep 2004; 53:304-6.
37. Quiroga R, Barrezueta O, Venczel L, et al. Interruption of indigenous measles transmission in Bolivia since October 2000. J Infect Dis 2003; 187(Suppl 1):S121-6.
38. PAHO. EPI Newsletter. 1999; 21:1-2.
39. Venczel L, Dobbins J, Andre J, et al. Measles eradication in the Americas: experience in Haiti. J Infect Dis 2003; 187(Suppl 1):S127-32.
40. CDC. Outbreak of measles-Venezuela and Colombia, 2001-2002. MMWR Morb Mortal Wkly Rep 2002; 51:757-60.
41. Castillo O, Rey G, Pastor D, et al. Measles outbreaks in Colombia, February-March 2002. Biomedica 2002; 22:219-29.
42. PAHO. EPI Newsletter. 1998; 20:2-3.
43. Isa MB, Martinez LC, Giordano MO, et al. Resurgence of measles in the province of Cordoba, Argentina, in 2000. Rev Argent Microbiol 2001; 33:229-34.
44. Isa MB, Gonzalez M, Martinex LC, et al. Measles outbreak in the province of Cordoba, Argentina in 1998. Rev Argent Microbiol 1999; 31:90-5.
45. Sniadack DH, Moscoso B, Aguilar R, et al. Measles epidemiology and outbreak response in a rural community in Peru. Bull World Health Organ 1999; 77:545-52.
46. Soula G, Sow S, Hien F, et al. Description et analyse d'une epidemie de rougeole a Bobo Dioulasso, Octobre 1995-Mai 1996. Bull Liais Doc OCEAC 1998; 31:22-34.
47. Grais RF, Conlan AJK, Ferrari MJ, et al. Time is of the essence: exploring a measles outbreak response vaccination in Niamey. Niger J.R. Soc Interface 2008; 5:67-74.
48. Grais RF, Ferrari MJ, Dubray C, et al. Estimating transmission intensity for a measles epidemic in Niamey, Niger: lessons for intervention. Trans R Soc Trop Med Hyg 2006; 100:867-73.
49. Grais RF, Dubray C, Gerstl S, et al. Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad. PLoS Med 2007; 4:e16.
50. Dubray C, Gervelmeyer A, Djibo A, et al. Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004). Vaccine 2006; 24:3984-9.
51. Nsungu M. Measles vaccination status, delay in recognizing measles outbreaks and outbreak outcome. Centr Afr J Med 1995; 41:336-9.
52. Puvimanasinghe JP, Arambepola CK, Abeysinghe NM, Rajapaksa LC, Kulatilaka TA. Measles outbreak in Sri Lanka, 1999-2000. J Infect Dis 2003; 187(Suppl 1):S241-5.
53. Thakur JS, Ratho RK, Bhatia SPS, et al. Measles outbreak in a periurban area of Chandigarh: need for improving vaccine coverage and strengthening surveillance. Indian J Pediatr 2002; 69:33-7.
54. Ratho RK, Mishra B, Singh T, Rao P, Kumar R. Letter to the editor: measles outbreak in a migrant population. Indian J Pediatr 2005; 72:893-4.
55. Mohan A, Murhekar MV, Wairgkar NS, et al. Measles transmission following the tsunami in a populationi with a high one-dose vaccination coverage, Tamil Nadu, India 2004-2005. BMC Inf Dis 2006; 6:143.
56. Marinova L, Kojouharova M, Mihneva Z. An ongoing measles outbreak in Bulgaria, 2009. Euro Surveill 2009; Vol 14:1-3.
57. Seguliev Z, Duric P, Petrovic V, Stefanovic S, Cosic G, et al. Current measles outbreak in Serbia: a preliminary report. Euro Surveill 2007; Vol 12:3115.
58. Ceylan A, Ertem M, Korukluoǧlu G, et al. An epidemic caused by measles virus type D6 in Turkey. Turk J Pediatr 2005; 47:309-15.